Form 4: Privia Health Group CEO Mehrotra Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Privia Health Group's CEO, Parth Mehrotra, sold 10,514 shares of common stock at $24.03 per share on March 12, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 12, 2025, Parth Mehrotra, the CEO of Privia Health Group, Inc., sold 10,514 shares of the company's common stock.
- The sale was executed at a price of $24.03 per share.
- This transaction was conducted under a pre-existing 10b5-1 trading plan.
- Following the transaction, Mehrotra directly owns 469,381 shares of Privia Health Group, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's performance.
Industry Context
Sales by insiders are a common occurrence, especially when executed under pre-arranged trading plans like 10b5-1 plans. These plans allow insiders to sell shares over a period of time without being accused of trading on non-public information. The market typically views these sales in the context of the overall insider ownership and the reasons behind the trading plan.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact given the existence of the 10b5-1 trading plan.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of the transaction: Sale of 10,514 shares of common stock by Parth Mehrotra. |
| 03/14/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.